• Tue. Sep 27th, 2022

Growing demand for invasive medical treatments is expected

ByMadeleine J. Pierce

Sep 1, 2022

South Korea, Seoul, September 02, 2022 (GLOBE NEWSWIRE) — Fact.MR – A market research and competitive intelligence provider: Global Syringe Market was valued at USD 14.2 Billion in 2020, and it is projected to reach USD 37 Billion by 2031, growing at a CAGR of 10% during the forecast period 2021-2031.

Syringe-based drug delivery is expected to be the most preferred treatment alternative, due to the relatively rapid onset of action compared to other oral medications. Because of this perception, syringes continue to dominate the healthcare industry. Additionally, the market is expected to grow by 2.6x.

Increased demand for invasive medical treatments and increased adoption of
Self-administration of drugs, medical device manufacturers are emphasizing the supply of key surgical instruments such as syringes.

In addition to this, medical professionals are also focusing on the advent of all-purpose syringes which can reduce the footprint of plastic syringes on a large scale.

For more market insights, request the brochure of this report

https://www.factmr.com/connectus/sample?flag=B&rep_id=59

Additionally, the growing reliance on biologic drugs to deliver faster results has increased the sales of injection drugs, resulting in greater traction in the global syringe market. In addition, due to their high complexity, biologics offer syringes for administration, stimulating many product launches in the global market.

Further, COVID-19 pandemic has resulted in accelerating the growth of syringe market due to its widespread application in the vaccination of people globally. Also, in 2020, according to the Biomedical Advanced Research and Development Authority (BARDA). 650 to 850 million syringes and needles will be needed in the United States. In addition to this, UNICEF had planned to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination efforts in various countries.

Key points to remember:

  • The United States is expected to be the most dominant market in North American regions due to the increasing geriatric population and Covid-19 vaccination campaigns. Additionally, in 2020, approximately US$2.5 billion worth of syringes were sold in the United States. Separately, the US government announced a public-private initiative, with the initiative to facilitate the production of more than 500 million in 2021.
  • Asia is expected to offer lucrative growth opportunities and is expected to show the highest growth rate, especially during the Covid-19 pandemic.
  • According to the end user, hospitals are expected to become the dominant end user of syringes. Additionally, over 66% of revenue is expected to be generated by hospitals.

Growth drivers:

  • Regions like Asia present lucrative opportunities for syringe manufacturers. It is expected to contribute to the growth of the market, especially amid the Covid-19 pandemic. In addition, as vaccination campaigns have been launched, the demand for syringes is expected to increase exponentially.
  • The increased use of biologic drugs to facilitate better outcomes has boosted injection drug sales. This is expected to drive the growth of the syringe market over the forecast period.
  • The increase in the global incidence of various chronic and infectious diseases is expected to drive the growth of the injectable drugs market.

For complete information, ask A Analyst Here

https://www.factmr.com/connectus/sample?flag=AE&rep_id=59

Competitive Landscape:

The global syringe market is competitive in nature. High capital investment to enter the market has created barriers for new market players. Moreover, the major market players are focusing their efforts on developing innovative products to establish their position in the global market.

  • In January 2021, Aurobindo Pharma Limited received final approval from the United States Food & Drug Administration (USFDA) to market the naloxone HCl 2 mg/2 mL prefilled syringe for injection.

Top Companies Featured by Fact.MR

  • Becton, Dickinson and company
  • B. Braun Melsungen AG
  • Gerresheimer S.A.
  • Hindustan Limited Syringes and Medical Devices
  • Terumo Company
  • Nipro Corporation
  • Schott SA
  • Medtronic Plc.
  • Smith’s Group Plc.
  • Codan Medizinische Geräte GmbH & Co Kg.

More valuable information about syringe market

Syringe market segmentation

  • type of product
    • General syringes
    • Specialty syringes
    • Conventional syringes
    • Safety syringes
    • Retractable syringes
    • Other syringes
  • Usability
    • Disposable syringes
    • Reusable syringes
  • Material
    • Glass syringes
    • Polymer syringes
  • Final user
    • Syringes for Hospitals
    • Syringes for blood collection centers
    • Syringes for diabetic care centers
    • Syringes for veterinary care centers
    • Syringes for other end users

Get customization on this report for specific research solutions

https://www.factmr.com/connectus/sample?flag=RC&rep_id=59

Explore Fact.MR’s Healthcare coverage

Blood Transfusion Diagnostics Market – The demand for blood transfusions has seen an upsurge in recent years. This is attributed to the large number of patients undergoing surgeries for various chronic diseases, such as aplastic anemia, sickle cell anemia, and leukemia. This has prompted key players to focus on the research and development of advanced instruments, tests and kits in blood banks and hospitals.

Genetic Testing Services Market – The genetic testing services market is expected to grow at a robust CAGR of 7.6% during the forecast period 2020-2025. The global market is expected to reach a value of US$64.1 billion by the end of 2025.

Fluid Management Market – The demand for intravenous administration of fluids and medications to chronically ill and dehydrated patients who are unresponsive to oral therapy is expected to drive the infusion therapy market. Projections indicate a modest CAGR of 5.3% over the forecast period.

High Flow Nasal Cannulas Market – According to the 2013 Global Burden of Disease Study, approximately 300 million people suffered from COPD in that year. This is attributed to the growing addiction to smoking, deteriorating air quality and increasing pollution across the world. The prevalence of respiratory disorders will further boost the market outlook.

Orthopedic Devices Market – The global orthopedic devices market is poised to grow moderately at a CAGR of 4.0% during the forecast period (2020-2026). This growth trajectory is attributed to the prevalence of a wide range of orthopedic disorders such as osteoarthritis, rheumatoid arthritis, fibromyalgia and juvenile arthritis. This is attributed to the prevalence of an aging population, lifestyle changes and obesity.

Immunoglobulin Market – The neurology segment held the maximum market share throughout the historical period, accounting for nearly 2/5 of the global immunoglobulin market. This trend is expected to continue throughout the forecast period. The immunology segment accounted for the 2nd largest share in the global immunoglobulin market and is poised to capture over 35% market share throughout the forecast period.

High Performance Liquid Chromatography (HPLC) Market – HPLC testing is a sophisticated and expensive analytical technique widely used in food processing as well as in the clinical diagnosis of diseases or disorders. It is used for drug analysis, molecule separation and environmental control in the pharmaceutical industry.

Medical Holography Market – The medical holography market was valued at US$447.8 million in 2019 and is expected to reach a value pool of US$3.5 billion by 2026, registering an excellent CAGR by 34.0% throughout the forecast period. This meets the growing demand for medical holographic imaging.

Ophthalmic Drugs Market – The global ophthalmic drugs market will gain moderate traction during the forecast period (2020-2025), registering a CAGR of 4.2%. There has been an increase in the incidence of eye diseases, especially in developing countries, in recent years.

About Fact.MR

Fact.MR is a market research and advisory agency with deep expertise in emerging market intelligence. Covering a wide range – from automotive and industry 4.0 to healthcare, technology, chemicals and materials, even to the most specialized categories. 80% of Fortune 1000 companies trust us with critical decision making. We provide qualitative and quantitative research, covering market forecasts, market segmentation, competitor analysis and consumer sentiment analysis.

Contact:

Mahendra Singh
USA Sales Office
11140 Rockville Pike
Office 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: [email protected]

Follow us: LinkedIn | Twitter